Prediction: SoundHound Passes $500 Million in Revenue Before It Turns a Profit
SoundHound grew second-quarter revenue 45% year over year to a record $61.9 million and now expects $230 million to $260 million for 2026.
Read moreLatest News
1 Unstoppable Cryptocurrency to Buy Before It Soars 270%
Bitcoin must grow at a nearly 40% annual rate to hit a price of $300,000 by 2030.
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85.
Rocket Lab CFO Dumps Over 140,000 Company Shares Worth $8.8 Million Amid a 28% One-Year Return
The transaction involved ~140,000 shares with an estimated value of ~$8.8 million at a weighted average price of $62.63 per share on September 2, 2026.
The S&P 500's Yield Is at Historic Lows. Here Are 3 Dividend Stocks I'd Buy in September.
McDonald's has raised its dividend for 49 straight years and currently offers a forward yield of 2.89%.
Grab COO Dumps 145,000 Company Shares After the Stock's 28% One-Year Decline
The transaction involved ~145,000 shares at an execution price of $3.48 per share, representing a total value of ~$506,000.
FDA Approves Guardant360 CDx Companion Diagnostic For ESR1-Mutated Breast Cancer
(RTTNews) - Guardant Health Inc. (GH) announced that the U.S. Food and Drug Administration approved Guardant360 CDx as a companion diagnostic or CDx to identify patients with hormo…
Billions in Iranian funds are passing through U.S. banks despite sanctions - WSJ
Iranian officials repeatedly say around 20 million liters of fuel are smuggled out of the country every day, costing Iran between $4 billion and $5.2 billion a year. But the figure…
Resideo SVP Mehta Buys 10,928 Shares in $226,000 Direct Purchase
Amit Ashvin Mehta, SVP, Strategy & Business Ops of Resideo Technologies (NYSE:REZI), executed a direct purchase of 10,928 shares of common stock on Aug. 17, 2026, according to a re…
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
Viking Therapeutics has significant upside potential based on Wall Street targets.
Imperial Petroleum earnings missed, revenue fell short of estimates
Imperial Oil Limited (TSE:IMO) missed earnings with its latest quarterly results, disappointing overly-optimistic forecasters. It wasn't a great result overall - while revenue fell…
Europe’s satellite launch ambitions take off as German rocket reaches orbit
He would like to thank the Fritz Thyssen Foundation for the travel grants that enabled a research visit to four Indian cities in July 2025. He would also like to thank Simona Becke…
AI’s Next Bottlenecks: Nvidia, Broadcom and CrowdStrike Move Up the Stack
Two prevailing narratives have driven markets recently. The first is that Nvidia Corp.’s moat is eroding primarily thanks to graphics processing unit alternatives such as tensor pr…
Bill Gates Says He Still Won't Invest in Crypto, Calls It a "Pure Mania-Driven Asset." Here's Why He's Right.
Microsoft co-founder Bill Gates was recently asked where he would put money if he wanted to diversify away from the U.S. dollar. His choices included gold, the euro, Chinese yuan, …
‘Poverty doesn’t have to be my reality’: I thought I’d have to rely on Social Security. Then I taught myself how to invest.
This is the true story of what happened when all the trauma was supposed to be over, when I left my “home” on the park bench on the outskirts of Salt Lake City for the last time in…
Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It
Cerebras grew its second-quarter adjusted revenue 103% year over year to $209.9 million.
IonQ vs. Rigetti Computing: Which Pure-Play Quantum Pioneer Has the Stronger Technology Advantage?
In the quantum computing investment sector, two popular stock picks are IonQ (NYSE: IONQ) and Rigetti Computing (NASDAQ: RGTI). Both of these quantum computing upstarts have a long…